MyFinsight
Home
Blog
About
Contact
Download
Download image
Gain on fair value
adjustments
$5,379,500
Research and development
incentive award
-$478,959
Interest income, net
$167,311
Total other income
$5,890,111
(loss) gain on foreign
currency transactions
-$135,659
Unrealized gain (loss) on
foreign currency...
$570,580
Income tax benefit
(expense)
-$34,794
Income (loss) before
income taxes
$1,829,298
Loss from operations
-$4,060,813
Total other
comprehensive income (loss)
$570,580
Net income (loss)
$1,864,092
Total operating
expenses
$4,060,813
Total comprehensive
income (loss)
$2,434,672
Restructuring costs
$1,236,172
General and
administrative
$2,126,918
Research and development
$697,723
Back
Back
Income Statement
source: myfinsight.com
Neuphoria Therapeutics Inc. (NEUP)
Neuphoria Therapeutics Inc. (NEUP)